Inir 80 80 mg hard gelatin capsules
PDF Leaflet Revision Date: 10 June 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of ADHD in children, adolescents, and adults.
Dosage (summary)
Children/adolescents: 0.5 mg/kg/day initially, max 1.2 mg/kg/day. Adults: 40 mg initially, max 80 mg/day.
Special Populations
- Hepatic impairment
- End-stage renal disease
Pregnancy & Breastfeeding
Not recommended during pregnancy; avoid during breastfeeding due to unknown excretion in human milk.
Key Drug Interactions
- MAOIs
- CYP2D6 inhibitors
- Antihypertensives
Contraindications
- Hypersensitivity to atomoxetine
- Uncontrolled hypertension
- Severe cardiovascular disorders
- Narrow angle glaucoma
Common side effects
- Decreased appetite
- Irritability
- Somnolence
- Palpitations
- Nausea
Counselling Points
- Monitor for suicidal thoughts
- Avoid eye contact with capsule contents
- Use caution when driving or operating machinery
Serious warnings
- Increased risk of suicidal ideation in children/adolescents
- Potential for psychotic symptoms
- Cardiovascular effects
Important Disclaimer
The Inir 80 80 mg hard gelatin capsules professional information leaflet below is the property of Dr Reddy’S Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
